E-Mail
The U.S. Congress and Biden-Harris administration have a clear opportunity to supercharge global health research and development (R&D) in the wake of a pandemic that has revealed both the sector's chronic neglect and amazing potential, according to a detailed agency-by-agency action plan released today by the nonprofit Global Health Technologies Coalition (GHTC).
"The same core capabilities instrumental to defeating COVID-19 can also defeat diseases that have plagued humanity for generations--such as AIDS, tuberculosis, malaria and Ebola--while targeting emerging pathogens of pandemic potential," said GHTC Director Jamie Bay Nishi. "Developing vaccines in such record-breaking time is, in reality, the product of decades of R&D investments. With smart funding and policy decisions, this foundation can generate a new era of innovations that will protect the health of millions of Americans and billions of people around the world."